CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 314 filers reported holding CONCENTRIX CORP in Q4 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,931,398 | -44.9% | 19,666 | -55.1% | 0.04% | -50.6% |
| Q3 2023 | $3,506,895 | +1.8% | 43,776 | +2.6% | 0.08% | +6.2% |
| Q2 2023 | $3,446,249 | +330.4% | 42,678 | +547.9% | 0.08% | +233.3% |
| Q1 2023 | $800,650 | +12.9% | 6,587 | +23.6% | 0.02% | +20.0% |
| Q4 2022 | $709,476 | +160.8% | 5,328 | +118.5% | 0.02% | +150.0% |
| Q3 2022 | $272,000 | -17.8% | 2,439 | 0.0% | 0.01% | -11.1% |
| Q2 2022 | $331,000 | -16.2% | 2,439 | +2.9% | 0.01% | 0.0% |
| Q1 2022 | $395,000 | -6.8% | 2,371 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $424,000 | +1.0% | 2,371 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $420,000 | +10.2% | 2,371 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $381,000 | -51.2% | 2,371 | -54.6% | 0.01% | -50.0% |
| Q1 2021 | $781,000 | +3.7% | 5,217 | -31.6% | 0.02% | -5.9% |
| Q4 2020 | $753,000 | – | 7,632 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |